The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of nivolumab (N) and cabozantinib (C) for treatment of the metastatic renal cell carcinoma (mRCC) in the Veneto region: Results of AMOUR study.
 
Marco Maruzzo
No Relationships to Disclose
 
Alberto Bortolami
No Relationships to Disclose
 
Dario Palleschi
No Relationships to Disclose
 
Andrea Zivi
No Relationships to Disclose
 
Maurizio Nicodemo
No Relationships to Disclose
 
Donata Sartori
No Relationships to Disclose
 
Rocco De Vivo
No Relationships to Disclose
 
Fable Zustovich
No Relationships to Disclose
 
Davide Bimbatti
No Relationships to Disclose
 
Davide Pastorelli
No Relationships to Disclose
 
Giuseppe Dione Vultaggio
No Relationships to Disclose
 
Mariella Soraru'
No Relationships to Disclose
 
Melissa Ballestrin
No Relationships to Disclose
 
Giulia Zanchetta
No Relationships to Disclose
 
Caterina Modonesi
No Relationships to Disclose
 
Paola Randisi
No Relationships to Disclose
 
Carmen Barile
No Relationships to Disclose
 
Gino Perri
No Relationships to Disclose
 
Umberto Basso
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag; MSD
Research Funding - Ipsen
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Pfizer; Sanofi
Other Relationship - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Sanofi/Aventis
 
Vittorina Zagonel
No Relationships to Disclose